ATLANTA – January 25, 2002 – 3dMD (www.3dMD.com), a pioneer in the future of digital patient imaging, announced that four new reputable hospitals from around the world have ordered the latest in clinically-accurate 3-D surface capture and application from 3dMD, while three other healthcare facilities are now utilizing 3dMD systems. 3dMD also announced its purchase, as well as the business of its parent company, London-based TCT international plc, by 3Q Technologies Limited (www.3Q.com).

With more than 30 customers worldwide, 3dMD is excited to report continued momentum for 3-D surface capture and application in healthcare. During the past few months, 3dMD has received orders from…

· Malaysia: Cybron Technology, a 3dMD distributor, on behalf of the Hospital Universiti Sains Malaysia for multidisciplinary use

· US: Connecticut-based Hartford Hospital for wounds management applications

· South Africa: AME International, a 3dMD distributor, on behalf of the Inkosi Albert Luthuli Central Hospital Kwa Zulu Natal for multidisciplinary use

· UK: Royal Hospital for Sick Children Edinburgh

…and commissioned new systems at:

· UK: London-based King’s College Hospital for chronic wounds management applications

· US: Atlanta-based Dent/AART for comprehensive restorative dentistry applications

· US: Illinois-based Decatur Memorial Hospital for burns assessment applications

“3dMD is 110-percent focused on exploiting clinically-accurate 3-D surface images in healthcare,” said Chris Lane, 3dMD’s CEO. “With our maturing portfolio of healthcare applications, the company is positioned to continue the momentum through Channel Partner programs, which are supported by an enthusiastic and ever growing user community.”

For the transaction, 3Q Technologies Ltd. purchased the whole of the TCT international plc business and technology, including its healthcare-focused subsidiary 3dMD. Headed by 3Q Technologies’ CEO Chris Lane, the former Managing Director and CEO of TCTi, 3dMD will continue to focus on 3-D surface imaging and application opportunities in healthcare. The Company will operate out of the existing offices in London (Harefield) and Atlanta, and is pleased to announce its new office location in San Francisco.

( back )